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We report here that unlike what was suggested for
many vertebrate neurons, synaptic transmission in Lym-
naea stagnalis occurs independent of a physical inter-
action between presynaptic calcium channels and a
functional complement of SNARE proteins. Instead, syn-
aptic transmission in Lymnaea requires the expression
of a C-terminal splice variant of the Lymnaea homolog to
mammalian N- and P/Q-type calcium channels. We show
that the alternately spliced region physically interacts
with the scaffolding proteins Mint1 and CASK, and that
synaptic transmission is abolished following RNA inter-
ference knockdown of CASK or after the injection of
peptide sequences designed to disrupt the calcium chan-
nel-Mint1 interactions. Our data suggest that Mint1 and
CASK may serve to localize the non-L-type channels at
the active zone and that synaptic transmission in inver-
tebrate neurons utilizes a mechanism for optimizing cal-
cium entry, which occurs independently of a physical
association between calcium channels and SNARE
proteins.
Calcium entry through voltage-gated calcium channels trig-
gers the release of synaptic vesicles in the presynaptic nerve
terminal. It is thought that the high calcium buffering capacity
of neurons necessitates that the sensor for calcium-triggered
exocytosis be situated close to the source of calcium entry, i.e.
near the inner mouth of presynaptic calcium channels (1–3).
Accordingly, a region within the cytoplasmic linker connecting
domains II–III of mammalian N- and P/Q-type calcium chan-
nels, termed the synaptic protein interaction (synprint) site,
was shown to bind tightly to a number of different proteins of
the presynaptic vesicle release complex, including syntaxin1A,
SNAP-25, and synaptotagmin1 (4–6). In mammalian neurons,
the requirement for a physical complex between presynaptic
calcium channels and the SNARE1 complex is supported by the
observation that injection of peptides corresponding to the syn-
print site blocks synaptic transmission, presumably through a
competitive decoupling of the SNARE protein-calcium channel
complex (2, 7–8).
The physiology of invertebrate synapses appears to correlate
closely with their mammalian counterparts. With few notable
exceptions, most vertebrate proteins involved in synaptic
transmission have structurally conserved orthologs in inverte-
brates (9). Surprisingly, however, none of the invertebrate cal-
cium channels identified from Drosophila or Caenorhabditis
elegans (10) appear to carry a structural motif that would
resemble synprint, indicating that a correlate role of synprint
does not exist in invertebrates. However, this postulate has not
yet been tested directly because invertebrate models that are
suitable for genetic analysis of synaptic transmission in the
central nervous system (such as C. elegans and Drosophila) are
not amenable to direct physiological analysis at the level of
single pre- and postsynaptic neurons. Conversely, most inver-
tebrate model systems that are amenable for physiological
analysis, until recently, lacked molecular information that is
required to interpret the physiological data.
To determine how transmitter release in invertebrates oc-
curs in the absence of calcium channels with a synprint motif,
we have taken advantage of identified Lymnaea neurons,
which are directly accessible to both physiological and molec-
ular analysis at the level of single pre- and postsynaptic neu-
rons. We have identified the sequences of the major calcium
channel subunits and key synaptic elements, including SNARE
proteins that are expressed in the presynaptic neuron. We
provide evidence that synaptic transmission is dependent on a
Lymnaea homolog of mammalian presynaptic calcium channels
that does not associate with the SNARE complex. Yet, despite
the lack of a synprint region in the Lymnaea channel isoform,
the injection of mammalian synprint peptide into Lymnaea
synapses still inhibits synaptic transmission. Thus, we chal-
lenge the current thinking of an unequivocal role of synprint in
the molecular assembly of synaptic proteins with calcium chan-
nels at the active synaptic zone. Instead, we show that synaptic
transmission in Lymnaea is critically dependent on the expres-
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sion of an alternatively spliced C-terminal region of the pre-
synaptic channel homolog that physically and functionally in-
teracts with the scaffolding proteins Mint1 and CASK. Our
data suggest that these proteins might be involved in anchor-
ing presynaptic calcium channels at the active zones, thus
optimizing calcium entry for transmitter release.
EXPERIMENTAL PROCEDURES
Molecular Cloning and Identification of Lymnaea Orthologs—Parts
of novel Lymnaea cDNAs were identified by PCR cloning using degen-
erate primers (see Table I), designed from regions with high sequence
identity in aligned protein orthologs described in the GenBankTM data
base (NCBI, Bethesda) using cDNA that was synthesized from brain
ganglia RNA of adult Lymnaea stagnalis.
cDNA clones were isolated by screening of ZAP cDNA libraries of
the Lymnaea central nervous system. Full-length cDNA clones were
generated, using primer walking and 5- and 3-rapid amplification of
cDNA ends. PCR fragments were amplified with DNA polymerases,
Herculase, or TurboPfu (Stratagene), and final sequences were assem-
bled from at least three independent PCRs. All sequencing was com-
pleted in both sense and antisense directions using ABI PRISM 310
Genetic Analyzer (Applied Biosystems, Inc., Foster City, CA).
Conceptual translations were derived from the longest open reading
frame. When the protein translation initiation site was uncertain, start
sites were inferred from closely related orthologs described in Gen-
BankTM. Lymnaea orthologs and results of comparison of sequence of
putative Lymnaea proteins with human orthologs are shown in Table I.
Sequence Alignments—BLASTP retrieved orthologs (GenBankTM) of
Lymnaea proteins were aligned by modified progressive pairwise, mul-
tiple alignment in PILEUP (UNIX-based, GCG Wisconsin Package
2002, Accelrys, Madison, WI) and were visually displayed (PLOTSIMI-
LARITY, Accelrys).
Quantitative PCR of Lymnaea Genes in Identified Neurons—Primer
pairs for qPCR detection of Lymnaea gene transcripts were designed
with Primer Express 1.0 software (Applied Biosystems). Each candidate
primer pair generated an amplicon of the expected size of 85–120 bp,
and PCR efficiencies were tested on Lymnaea central nervous system
cDNA using serial dilutions of template. Primer dimers were identified
by measurable product in the absence of qPCR template. All qPCR
primer pairs (see Table I) averaged an amplification efficiency of
1.9–2.0.
cDNA templates for the qPCR were prepared from single, identified
neurons with axons attached by gentle mechanical suction with pulling
pipette from each of six Lymnaea brain ganglia preparations. cDNA
were synthesized as follows: 1) directly from freshly isolated neurons; 2)
as unpaired pre- and postsynaptic neurons after 18 h of primary culture
on hemolymph-coated coverslips; or 3) as synaptically paired neurons
cultured for 18 h (see primary cell culture technique described below for
more details).
The freshly isolated and cultured cells were transferred as a collec-
tive into a prepared microcentrifuge tube in a minimal volume of
culture medium (3 l) for immediate total RNA isolation and first
strand synthesis, using a protocol as described by Van Kesteren et al.
(14). For qPCR, primer pairs at 2 pmol each were used in a final PCR
volume of 20 l, using a master-mix of SYBR Green PCR core reagents.
The threshold line for determining the value of the cycle of threshold,
Ct, was set on 0.3 Rn (base-line subtracted values) with curves reach-
ing maximally 6–8 Rn and base lines of 0.02 Rn. Data were
considered only if the CT values of control and experimental samples
were 8 cycles. The overall cDNA expression levels per sample were
normalized to the expression of controls L-aldolase and to L--tubulin
which both show consistent expression for each cell type, and corre-
sponded proportionally to the different cell diameters.
In Vitro Binding and Yeast Two-hybrid Analyses—Bacterial fusion
proteins used in binding assays were constructed by inserting PCR-
amplified DNA in-frame into pTRCHis or pRSET (Invitrogen) or pGEX
(Amersham Biosciences). Fusion proteins for studying yeast two-hybrid
interactions were prepared in-frame with bait LexA DNA binding do-
main of pHybLex and prey B42 activation domain of pYESTrp2. The
following fusion protein constructs for expression were prepared (name,
protein residue numbers, vector) as follows: rat Cav2.2 synprint: 718–
963, pTRCHisC; rat stx1A: 1–268, pGEX-KG; LCav2a N terminus:
1–67, pYESTrp2; LCav2a I–II linker: 346–509, pYESTrp2, LCav2b
II–III linker: 714–888, pRSETA. LCav2a III–IV linker: 1148–1205,
pYESTrp2; LCav2a C terminus (CT) CT1: 1596–2141, pRSETC,
pGEX4T-1, pYESTrp2; LCav2a CT2: 1996–2141, pGEX4T-1,
pYESTrp2; LCav2a CT3: 1447–1722, pYESTrp2; Lstx1A: 1–270, pGEX-
4T-1, pHybLex; LSNAP25: 1–220, pGEX-4T-1; LsytI: 1–418, pGEX-
4T-1, Lmint: 916–1138, pHybLex; LCASK: 576–861, pHybLex.
Detailed methods for the bacterial expression, purification, and in
vitro binding assay of the fusion proteins have been described previ-
ously (11–12). All fusion protein constructs were verified by sequencing
and evaluated for measurable expressibility on a size-selected SDS-
PAGE gel, using Coomassie Blue protein stain. Preparation of protein
extracts of Lymnaea brain ganglia and Western blot analysis were
performed as described previously (11). Lymnaea syntaxin1A was de-
tected by commercial antibody (ANR-002, Alomone Labs, Jerusalem,
Israel). For analysis of two-hybrid interactions, yeast bait and prey
fusion vectors were transformed into L40 Saccharomyces cerevisiae
strain, and the binding affinity of the interactions was measured by
-galactosidase activity using o-nitrophenyl--D-galactoside substrate,
qualitatively by filter lift according to manufacturer’s instructions
(Hybrid Hunter, Invitrogen) and quantitatively in liquid extracts.
Primary Cell Culture—Identified neurons of L. stagnalis were iso-
lated and cultured in either a soma-soma configuration or neurite-
neurite configuration as described previously (13). In knockdown
experiments, identified neurons were initially plated on hemolymph-
pretreated glass coverslips (to prevent neuronal adhesion) in condi-
tioned medium bathed in 10 M antisense/mismatch DNA oligonucleo-
tide probes (14) or 10 g of dsRNA (for RNA interference) for 3 days.
The oligonucleotide or dsRNA-treated neurons were then transferred
and paired on poly-L-lysine-pretreated glass coverslips in the presence
of CM. In some knockdown experiments, RNAi-treated neurons were
tested for non-synaptic release using a “sniffer cell” (15) Transmitter
release was detected from a dopamine-releasing cell, RPeD1, using one
of its postsynaptic neurons, VK, which displays a depolarizing response
to dopamine.
Antisense and RNAi Treatment—15-mer double-stranded DNA anti-
sense calcium channel probes were designed across the start site of
LCav2: GAACGTGGCCATCCA (95–109), a sequence shared in all Lym-
naea isoforms identified. Mismatch probes for LCav2 consisted of three
base changes to the antisense sequence GAAGGTGCCCAACCA. Before
treatment to neurons, antisense/mismatch probes were reconstituted in
Lymnaea saline, passed through a 0.8-m filter, boiled for 2 min, and
cooled on ice.
For RNA interference technique, dsRNA probes were synthesized by
the transcription in both sense and antisense strands (MEGASCRIPT;
Ambion, Austin, TX) using T7 and T3 promoters in Bluescript II KS
vector between base pairs 2237 and 2710 (II–IIII loop LCav2a), 2237–
2761 (II–III loop LCav2b), 6083–6520 (C-terminal LCav2a), and 1893–
2750 (LCASK). RNA probes were resuspended in Lymnaea saline,
boiled for 2 min, incubated at 65 °C for 15 min, and then allowed to cool
to room temperature, enabling single complementary RNA strands to
anneal properly. RNA samples were analyzed by agarose gel
electrophoresis.
Electrophysiology—Synaptic transmission was monitored by simul-
taneous intracellular recordings of pre- and postsynaptic neurons using
hardware and acquisition/analysis software as described previously
(13). Calcium channel activities of VD4 neurons were measured using
established whole-cell recording technique (16).
RESULTS
Lymnaea Neurons Express Homologs of Mammalian Cal-
cium Channels and SNARE Proteins—The Lymnaea soma-
soma synapse is a rapidly emerging model for investigating
synaptic function. Until recently, the full potential of this sys-
tem had not been realized due to lack of genomic information.
We have thus used degenerate PCR cloning and screening of
Lymnaea cDNA libraries of whole brain ganglia to identify
orthologs of presynaptic vesicle release proteins and of the
pore-forming1subunitsofthestructuralsuperfamilyofvoltage-
dependent calcium channels. Lymnaea calcium channel or-
thologs include representatives of the major high voltage-acti-
vated (HVA) calcium channel classes, L-type (LCav1) and
non-L-type (LCav2), and (LVA) T-type (LCav3) channels, as
well as a calcium channel  subunit (LCavb). In addition, we
identified a representative of the functionally unidentified
class, dubbed U-type (17). These subunits (four 1 and one )
are reminiscent of the representation in Drosophila and C.
elegans genomes (10) and likely provide a complete comple-
ment of such genes in the Lymnaea nervous system.
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LCav2 is a structural homolog of both mammalian N-
(Cav2.2) and P/Q-type (Cav2.1) calcium channels considered
responsible for transmitter release at mammalian synapses
(18–19), and of invertebrate gene relatives in Drosophila
(DmCa1A/cac) and C. elegans (unc-2) (20–22) (see Fig. 1A).
From an alignment of various Cav2 homologs (Fig. 1, C and D),
a high degree of sequence conservation is seen in the  subunit
interaction site in the domain I–II linker (AID sequence) (23)
and in the major transmembrane domains, but no apparent
sequence identity is evident in the domain II–III linker, the
locus of the synaptic protein interaction (synprint) site in ver-
tebrate channels (Fig. 1, C and D). Indeed, the II–III linker
region in LCav2 appears considerably shorter than that of
vertebrate Cav2 channels, and repeated attempts to identify an
LCav2 channel with a longer, synprint-containing II–III linker
in Lymnaea cDNA were unsuccessful. In trying to do so, how-
ever, we isolated an additional LCav2 isoform (LCav2b) that
varied by 17 amino acids in the II–III linker (see Fig. 1). The
apparent lack of the synprint motif in Lymnaea and other
invertebrates contrasts with the high sequence homology
among presynaptic vesicle release proteins such as syntaxin1A,
SNAP-25, and synaptotagmin1 (see Table I). Taken together,
these observations indicate that although SNARE proteins are
highly conserved throughout evolution, the appearance of a
synprint motif may be an evolutionary specialization in
vertebrates.
Single-cell Analysis of Transcript Expression in an Identified
Presynaptic Neuron—To demonstrate the expression of the
identified calcium channel genes, we examined mRNA tran-
scripts in single identified pre- and postsynaptic neurons that
are major players in our established soma-soma and neurite-
neurite synapse models (13, 24). To ensure unequivocal iden-
tification of the cell type, we first acquired an expression profile
of cell type-specific markers in three identified neurons as
follows: visceral dorsal 4 (VD4), left pedal dorsal 1 (LPeD1),
and right pedal dorsal 1 (RPeD1) which form a critical compo-
nent of a central respiratory rhythm-generating network. Cells
were individually isolated from the intact ganglia and sub-
jected to quantitative, real time PCR (qPCR) analysis. For
cholinergic/peptidergic presynaptic VD4 neurons, we detected
characteristically high LVAchT (vesicular acetylcholine trans-
porter) and LFMRFamide heptapeptide gene expression levels
(Fig. 2). In contrast, the postsynaptic serotonergic neuron
(LPeD1) and giant dopamine cell (RPeD1) typically display the
higher expression levels of LVMAT, the vesicular transporter
for monoamines (Fig. 2, inset). We then performed real time
qPCR in the presynaptic VD4 neuron, using specific primers for
the three major types of voltage-gated calcium channels. As
seen in Fig. 2, all types of calcium channel 1 subunits, as well
as the  subunit were present in measurable abundance in
VD4, including the two C-terminal splice variants of both the
LCav1 and LCav2 channels (Fig. 2). In addition, expression of a
number of key synaptic proteins such as VAMP, syntaxin1A,
SNAP-25, synaptotagmin1, and nsec1/munc18–1 was also de-
tected (not shown, but see Fig. 7D). Hence, Lymnaea VD4
neurons robustly express many of the proteins thought to be
FIG. 1. Comparison of vertebrate and invertebrate orthologs of Cav2 calcium channels. A, phylogram of Cav2 1 subunits. A single
maximum parsimony tree obtained using the heuristic algorithm in PAUP*4.0b8. Numbers on the branches are bootstrap support values. B,
transmembrane topology of the calcium channel 1 subunit, indicating the absence of the synaptic protein interaction site in invertebrate calcium
channels, and the location of proline-rich and DDWC motifs in the C terminus. C, region size (mean and S.E.) of the cytoplasmic domain I–II and
II–III linkers in Cav1 and Cav2 representatives from invertebrates (jellyfish, flatworm, nematode, two insects, snail, and squid) and vertebrates
(tunicate, fish, marine ray, frog, chicken, rabbit, hamster, mouse, rat, and human) and a human Cav2.2 splice variant (1B-2) lacking the synprint
site (37). Note that the extended, synprint-containing II–III linker region seems exclusive to vertebrate Cav2 channels. D, similarity between
multialigned amino acid sequences of full-length, Cav2 calcium channel 1 subunits from invertebrates (C. elegans, Drosophila, and Lymnaea) and
human homologs (1A, 1B, and 1E). Highlighted with boxes are highly conserved regions corresponding to the major transmembrane domains (D1
through D4), and three cytoplasmic regions associated with putatively ascribed binding partners:  subunits (AID), calcium, and calmodulin
(EF-hand/IQ motifs) and Mint1 (“(D/E)_WC” motif). The synprint region contained in the II–III linker is not conserved among putative full-length
Cav2 isoforms.
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involved in mammalian synaptic transmission.
To minimize the possibility that an unidentified LCav2 do-
main II–III linker splice isoform with a synprint-like motif
could exist in Lymnaea neurons, we examined the relative
abundance of the LCav2 II–III linkers relative to the domain
I–II linker region of LCav2 which is highly conserved (23) and,
thus, a measure of the overall levels of LCav2 transcript. As
seen in Fig. 2, when we used primers that specifically detected
common sequences in both LCav2a and LCav2b but did not
produce any gel bands of longer sizes (not shown), we found
that the expression of the short II–III linker was strikingly
similar to that of the I–II linker. These data suggest that the
identified short II–III linkers of LCav2a and LCav2b predomi-
nate in VD4, and if an isoform of LCav2 with an identifiable
synprint-containing domain II–III loop were to exist, it can only
be of low and almost immeasurable abundance.
Gene Knockdown of Lymnaea Presynaptic Calcium Channels
Perturbs Synaptic Transmission—To assess the role of LCav2
channels in neurotransmitter release, the presynaptic cell VD4
was pre-treated with antisense and subsequently paired with
its postsynaptic partner LPeD1. Specifically, antisense (15-
mer) probes were designed at the start site of LCav2 channels,
and presynaptic VD4 neurons were pre-incubated at a concen-
tration of 10 M for 3 days before synaptic pairing with postsyn-
aptic LPeD1 neuron. Synapses were subsequently tested with
simultaneous intracellular recordings. Unlike control condi-
tions, or in cells injected with mismatch antisense probes (Fig.
3A, n  12), excitatory synaptic transmission was perturbed
between the soma-soma paired cells (Fig. 3A, n  9) in which
VD4 cells were selectively treated with antisense-LCav2 prior
to pairing with LPeD1. Under these experimental conditions,
the postsynaptic LPeD1 cells, however, continued to exhibit an
excitatory response to exogenously applied ACh, suggesting
that the antisense treatment did not affect the postsynaptic cell
(Fig. 3A). Pre-treatment of VD4 with LCav1-antisense had only
a minor effect on synaptic transmission that appeared as a
fatiguing of the postsynaptic response over time (not shown).
To complement the antisense experiments, we utilized RNA
interference (RNAi) techniques to degrade catalytically mRNA
in VD4 prior to its pairing with LPeD1. Double-stranded
RNA probes were designed against the short II–III linkers
found in both LCav2a and LCav2b. VD4 was incubated for 3
days prior to soma-soma pairing in 8–10 g of these RNAi
probes. To test for the effectiveness of the RNAi knockdown,
total HVA barium currents were measured in whole-cell patch
configuration (Fig. 3B). RNA interference of LCav2 resulted in
a dramatic depression of HVA currents, leaving only a residual
current with noticeably different inactivation kinetics, which
may be due to LCav1, the other HVA channel type identified in
VD4. Synaptic transmission was completely abolished with
FIG. 2. Quantification of calcium channel mRNAs in VD4 neu-
rons. Gene expression measurements using real time qPCR of cDNA
synthesized from mRNA of identified neurons freshly isolated from six
Lymnaea central nerve ring ganglia (mean  S.E., n  6). Data are
represented as the cycle threshold of detection (CT), normalized to the
expression of control marker gene, L-aldolase. Main panel, expression
profile of calcium channel 1 subunits (LCav1 to Cav4) and  subunit in
VD4. For both LCav1 to LCav2, both the full-length, a isoform (C-term
) and C-terminally truncated b isoforms (C-term 	) are detected.
Inset, expression profile of cell type-specific marker genes in identified
VD4, LPeD1, and RPeD1 neurons. For presynaptic VD4 neurons, the
cholinergic/peptidergic neuron phenotype in each sample is confirmed
(i.e. high LVAchT and LFMRFamide heptapeptide gene expression).
The postsynaptic serotonergic neuron (LPeD1) and giant dopamine cell
(RPeD1) shows the expected serotonin/dopamine phenotype (i.e. high
levels of LVMAT).
FIG. 3. Transmitter release requires the LCav2 channel. A, iso-
lated VD4 and LPeD1 neurons were treated with 10 M, 15-mer anti-
sense, or mismatch oligonucleotide probes directed against the start
site of LCav2. In pairs treated with antisense probes (n  9), trains of
action potentials induced in VD4 (arrow) failed to evoke a postsynaptic
response in LPeD1. In pairs treated with mismatch probes (n  12),
however, action potentials in VD4 (arrow) elicit 1:1 EPSPs in the
postsynaptic LPeD1 neuron. LCav2 knockdown does not affect the
postsynaptic cell, which is still responsive to exogenously applied ACh.
B, RNAi knockdown of the LCav2 gene in VD4 reduces the HVA barium
current densities, revealing altered kinetics of the remaining currents.
Sample recordings display representative currents for both control (n
6) and RNAi (n  5)-treated cells. C, knockdown of the LCav2 gene via
RNA interference. When the pre- and postsynaptic neurons were
treated with 10 g of RNAi directed against the II–III linker of LCav2,
synaptic transmission was perturbed (n  7). Induced trains of action
potentials in VD4 (arrow) fail to elicit a postsynaptic response in
LPeD1. In contrast, under control conditions, induced action potentials
in VD4 (arrow) elicit 1:1 EPSPs in LPeD1. D, knockdown of the LCav2
gene with RNAi perturbs nonsynaptic release of transmitter. Transmit-
ter release from the dopamine releasing cell RPeD1 (n  13) was
detected using a sniffer cell, VK, that depolarizes in response to dopa-
mine. Unlike control cells (n  9), in RNAi treated cells, trains of action
potentials in RPeD1 (arrow) fail to elicit a response in the sniffer cell
VK.
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selective RNAi knockdown of the gene containing the identified
short II–III linker (Fig. 3C, n  7). As RNAi knockdown was
targeted specifically to this LCav2 sequence, the absence of a
postsynaptic response indicates that neurotransmission relies
exclusively on a calcium channel homolog that lacks a synprint
motif in the II–III linker.
From the experiment shown in Fig. 3C, it was unclear
whether the lack of synaptic transmission was due to the in-
ability of the VD4 neuron to release neurotransmitter or a
consequence of a change in synaptic architecture that pre-
vented the postsynaptic cell from detecting transmitter re-
leased from VD4. To discriminate among these possibilities,
the dopaminergic neuron RPeD1 was pre-treated with LCav2
RNAi as described above. Transmitter release was detected
from RPeD1 as a function of non-synaptic electrophysiological
responses in a “sniffer” cell (15). After RNAi treatment, RPeD1
somata were plated on poly-L-lysine-coated dishes, and a
freshly isolated soma of one of its postsynaptic neurons (vis-
ceral K, VK) was manipulated in close proximity to RPeD1 to
detect induced release of transmitter. RNAi treatment of
RPeD1 rendered this cell incapable of transmitter release (Fig.
3D, n  13). In contrast, under control conditions, 100% of
RPeD1 cells released dopamine that was detected at some
distance by the sniffer cell (Fig. 3D, n  9). These data indicate
that the loss in synaptic transmission between VD4 and LPeD1
neurons was likely due to a direct effect on neurotransmitter
release.
Taken together, the above data indicate that, like in mam-
malian neurons, Cav2 calcium channels are required for trans-
mitter release in Lymnaea neurons.
Lymnaea Synaptic Transmission Depends on SNARE Pro-
teins but Not on Their Interactions with the Lca22 Channels—
Previous work (25) in other invertebrate systems suggests that
synaptic transmission in Lymnaea may also rely on the SNARE
proteins syntaxin1A and SNAP-25. As shown in Fig. 4A, injec-
tion of 1 M Botulinum toxin (Bt) C1 or BtE into presynaptic
VD4 neurons paired with LPeD1 abolished synaptic transmis-
sion between these neurons (Fig. 4A; n 6 and 5, respectively),
without affecting the response of the postsynaptic neuron to
exogenously applied ACh, the transmitter used at the VD4-
LPeD1 synapse (not shown). Hence, as expected a functional
complement of LSNAREs in the presynaptic cell is required for
transmitter release.
The absence of the synprint motif in LCav2, however, predicts
that Lymnaea synaptic proteins such as syntaxin1A, SNAP-25,
and synaptotagmin1 should not be able to interact with the II–III
linker. Indeed, as shown in Fig. 4, there was no measurable
association of the Lymnaea II–III linker with GST-Lstx1A, GST-
LSNAP25, or GST-Lsyt1 (Fig. 4B) in direct binding assays,
whereas comparable amounts of Lymnaea synaptic proteins
readily bound to the positive control, rat His6 synprint (Fig. 4B).
We also did not detect binding of these proteins to the LCav2 C
terminus (Fig. 4C), N terminus, domain I–II linker, and domain
III–IV linker region in vitro, or in a yeast two-hybrid assay (not
shown). Moreover, neither the II–III linker nor the C-terminal
region bound syntaxin1A in protein extracts of Lymnaea whole
brain ganglia (Fig. 4C), indicating that syntaxin1A is not coupled
to these regions of the LCav2 channel via adaptor proteins. In
contrast, there was consistent, dose-dependent binding of rat
synprint to Lymnaea syntaxin1A from brain extracts (Fig. 4C).
Overall, these data indicate that Lymnaea orthologs of
syntaxin1A, SNAP-25, and synaptotagmin1, although poten-
tially capable of interacting with rat synprint, do not associate
with the major cytoplasmic regions of the Lymnaea homolog of
presynaptic calcium channels and thus are unlikely to interact
with this channel altogether.
Synprint Peptide Injection into VD4 Perturbs Synaptic
Transmission—Synprint peptides injected into mammalian
SCG neurons disrupt synaptic transmission, perhaps by com-
petitively inhibiting the interaction between syntaxin1A and/or
SNAP-25 to N-and P/Q-type channels (7). Because the Lym-
naea channel ortholog lacks synprint and consequently does
not appear to associate with these proteins, one would expect
that mammalian synprint peptide injected into Lymnaea VD4
neurons should not affect neurotransmission. Surprisingly, the
injection of 8–10 pM of rat synprint peptide into VD4 neurons
1–4 h prior to recording interfered with synaptic transmission
between VD4-LPeD1 pairs (Fig. 5, n  13). In 7 of 13 synprint-
injected cells, a complete blockade of transmission was ob-
served. In the remaining synapses a marked use-dependent
perturbation of synaptic transmission was noted, such that
during a series of 10 action potentials, the postsynaptic re-
sponse became reduced to 32% of the amplitude of the initial
EPSP (Fig. 5, C and D). These results suggest that the site of
synprint peptide action was initially inaccessible but became
incrementally exposed to synprint by repetitive presynaptic
stimuli. The presence of the synprint peptide per se did not
affect current densities or the biophysical properties of Lym-
naea calcium currents (not shown), indicating that the effects
of these peptides occurred independently of an action on cal-
cium channels. To ensure that the effects of the synprint pep-
tide were specific, we generated a peptide of the domain II–III
linker region of the Lymnaea Cav2 calcium channel which, as
FIG. 4. Lymnaea synaptic transmission depends on SNARE
proteins, but not on SNARE protein-calcium channel interac-
tions. A, effect of Botulinum toxins (Bt) on synaptic transmission in
Lymnaea. Unlike in control pairs (n  6), in VD4 neurons injected with
BtC1 (n  6) or BtE (n  5), a train of action potentials (arrow) in VD4
failed to elicit a postsynaptic response in LPeD1. B, in vitro binding of
His6-LCav2a II–III linker (left panel) or the positive control His6-rat
Cav2.2 synprint (right panel) to incremental amounts of 20, 40, or 80 l
of a 50% slurry of Lymnaea syntaxin1A, SNAP-25, and synaptotag-
min1. Western blots were probed with an Anti-Xpress antibody. C, in
vitro experiments involving the binding of 230 g of Lymnaea brain
ganglia extracts to immobilized His6- LCav2b II–III linker (80 l),
His6-LCav2a C terminus (80 l), and His6-rat Cav2.2 synprint (20, 40
and 80 l) under identical experimental conditions.
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shown in Fig. 4B, is incapable of interacting with syntaxin 1,
SNAP-25, or synaptotagmin. Injection of this peptide into VD4
neurons did not significantly affect synaptic transmission be-
tween the paired cells (Fig. 5, A, B, and D). This observation is
reminiscent of the inability of rat L-type calcium channel II–III
linker peptides to alter synaptic transmission in rat SCG neu-
rons (7), and supports the specificity of the synprint peptide
effects illustrated in Fig. 5.
Overall, our data suggest that synaptic transmission be-
tween Lymnaea neurons exhibits many of the hallmarks of
mammalian neurotransmission but seems to occur without
physical tethering of presynaptic vesicle release complex to a
synprint region in presynaptic calcium channels. Mammalian
synprint peptides can nonetheless interfere with neurotrans-
mitter release perhaps by inactivating other synaptic elements
that make use of the synprint motif.
Alternative Splicing of the Non-L-type Channel Regulates
Lymnaea Neurotransmission—As noted above, two splice vari-
ants of the LCav2 channel with different C-terminal tails are
expressed in VD4 neurons (Fig. 2). To determine the signifi-
cance of this observation for synaptic transmission, we de-
signed a specific RNAi probe against the variant with the
extended C terminus, and we assessed its effect on synaptic
transmission between VD4 and LPeD1. The selective depletion
of the longer C-terminal LCav2 variant completely abolished
synaptic transmission in 6 of the 9 cells examined, and in the
remaining synapses, EPSP amplitude was reduced to 2.1  0.2
mV (see Fig. 6A). The loss in synaptic transmission was accom-
panied by a significant reduction (22.4  3.01 pA/pF, n  7; p 
0.001 versus control) in HVA current densities in RNAi-treated
cells (Fig. 6B). Although this reduction was substantial, it was
nonetheless significantly (p 0.02) smaller than that seen in Fig.
3B which was designed to eliminate all LCav2 expression. In-
deed, the data shown in Figs. 3B and 6B are consistent with the
observation that the LCav2a channel comprises a larger fraction
of the total LCav2 calcium mRNA transcript level (see Fig. 2).
The notion that an alternately spliced C-terminal sequence
appears to be essential for synaptic release raises the possibil-
ity that this region might be involved in protein-protein inter-
actions at the synapse. To test this possibility, we injected a
FIG. 6. Alternative splicing of LCav2 is essential for synaptic
transmission. A, effect of selective RNAi knockdown of the long form
C-terminal splice variant of the LCav2 Ca
2 channel on EPSPs. The
experimental conditions were as outlined in Fig. 3, B and C, but the
RNAi probe was directed against the alternately spliced C-terminal
region. Note that in 6 of 9 synapses examined, synaptic transmission
was undetectable, whereas in the remaining pairs, EPSP amplitude
decreased to about 30% of the control value. B, current densities in
control cells, and in cells depleted of the LCav2 C-terminal splice vari-
ant. The control data are the same as those shown in Fig. 3B. C and D,
effect of injection of a peptide (CT1) corresponding to the alternately
spliced C-terminal region in LCav2a on synaptic transmission in form of
sample traces (C) or a bar graph (D). Note that this peptide drastically
depresses EPSPs in paired VD4/LPeD1 neurons.
FIG. 5. Synprint peptides prevent Lymnaea synaptic transmission. A and B, sample recordings (A) and bar graph (B) (mean EPSP
amplitude  S.D.) representing control pairs or pairs in which the presynaptic VD4 neuron was injected with rat Cav2.2 synprint, or the Lymnaea
Cav2 II–III linker. In 50% (n  13) of the synprint injected pairs, synaptic transmission is completely abolished (not shown). In the remaining
synprint injected pairs, the average EPSP amplitude is 2.26  0.40 mV. In control and LCav2 II–III linker injected pairs, synaptic transmission
was normal. Single action potentials induced in VD4 (arrow) elicited 1:1 EPSPs with average amplitude of 6.6 0.96 mV (control, n 6) and 6.6
0.72 mV (LCav2 II–III linker, n  8). C and D, the effect of synprint displays marked use dependence. In these experiments, all neuron pairs were
subjected to a series of 10 action potentials with 30 s between each action potential. Unlike in control cells, or in cells injected with LCav2 II–III
linker (not shown), in synprint injected pairs (top panel), the EPSP induced by the 10th action potential is on average 32% smaller than that
induced by the 1st action potential. The graph in D demonstrates the use-dependent blockade of synaptic transmission in synprint injected neurons
(closed circles). The remaining pairs injected with synprint do not display synaptic transmission at any time during our recordings (closed
triangles). In control (open circles) and LCav2 II–III linker injected (open triangles) pairs, the amplitude of EPSPs remains relatively constant.
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peptide (CT1, see also Fig. 7A) directed against this region into
VD4 neurons 1 h prior to recording. As shown in Fig. 6, C and
D, this resulted in a dramatic inhibition of synaptic transmis-
sion, consistent with the notion that the peptide may have
competitively inhibited an interaction between the non-L-type
channel C-terminal region and an essential presynaptic
protein.
Synaptic Transmission Depends on CASK and Mint1—The
alternately spliced C-terminal region in LCav2a contains a
proline-rich region with multiple PXXP consensus sites for
putative association with SH3 domains, as well as a character-
istic (D/E)XWC motif at the C-terminal, 3 end (see Figs. 1D
and 7A). Both the (D/E)XWC and an upstream proline-rich
region are highly conserved in mammalian N- and P/Q-type
calcium channels, where they have been shown to bind specif-
ically to the first of two PDZ domains of Mint1 and SH3 do-
mains of CASK, respectively (26–27). To determine whether
LCav2 C terminus could interact with Mint1 and CASK in
vitro, we employed a yeast two-hybrid assay, using the LCav2a
C terminus as bait and Lymnaea Mint1 and CASK as prey. We
detected a robust interaction (Fig. 7A) with CASK binding to a
fragment containing a proline-rich sequence (CT3), whereas
Mint1 bound downstream specifically to the C-terminal tail
containing DDWC motif (CT2). Mint1 binding was virtually
abolished when we introduced a single amino acid mutation
W2140K into the CT2 peptide sequence, converting Lymnaea
LCav2a DDWC sequence to DDKC, the terminal amino acids
reminiscent of rat 1E channels (Fig. 7A) (26). Hence, in anal-
ogy to what has been reported for rat N-type calcium channels,
Mint1 and CASK can bind to the LCav2 carboxyl tail, raising
the possibility that these interactions might be critically in-
volved in neurotransmission. To test this possibility, we first
treated VD4 neurons with RNAi to CASK. This resulted in
block of synaptic activity in 4 of 7 experiments and dramati-
cally reduced EPSP amplitude in the remaining cells (Fig. 7B),
indicating that CASK is essential for synaptic function. More-
over, this is consistent with the possibility that an interaction
between CASK and the LCav2 C terminus is required to ensure
proper neurotransmitter release. There was no detectable
change in calcium current density or the biophysical charac-
FIG. 7. Mint1 and CASK regulate Lymnaea neurotransmission. A, yeast two-hybrid assay illustrating the binding of Mint1 and CASK to
the alternatively spliced C-terminal region of LCav2. Both Mint1 and CASK bind to this region but to separate domains with Mint1 interacting
with the extreme C-terminal tail (CT2 region), and CASK binding to an upstream proline-rich region (CT3 region). Site-directed mutagenesis of
the tail of the CT2 peptide from DDWC to DDKC abolishes the Mint interaction. Data are expressed in form of -galactosidase activity determined
from liquid extracts. The top of the figure depicts a graphic representation of the LCav2 channel C-terminal region with the location of CT peptides
illustrated above. B, sample traces showing that RNAi depletion of VD4 neurons of CASK greatly reduced neurotransmission. In 4 of 7 cells, no
EPSPs could be detected, whereas in the remaining cells they were greatly reduced. C, effect of injection of CASK interacting CT3 peptides and
of wild type and DDKC mutant LCav2 CT2 peptides into VD4 neurons on synaptic transmission. Note that the wild type CT2 peptide disrupted
neurotransmitter release, whereas the mutant CT2 peptide and the CT3 peptide did not. D, qPCR analysis of gene expression of cultured VD4 and
LPeD1 neurons, comparing those cultured overnight as VD4/LPeD1 synaptic pairs or unpaired. Whereas the expression of synaptic proteins such
as syntaxin1A (Lstx1A) and synaptotagmin1 (Lsyt1) or calcium channels is not regulated during synapse formation, the expression of LMint1 is
dramatically increased in paired cells. Inset, gene expression levels of Lsyt1 and LMint1 in unpaired neurons and synaptic pairs. Data are
represented as the cycle threshold of detection (CT), normalized to the expression of L-aldolase. Note the virtual absence of LMint1 in unpaired
neurons. Also note that these experiments differ from those shown in Fig. 2, where only freshly isolated neurons of a single identified type were
used for analysis under each condition.
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teristics of the channels after CASK RNAi treatment or in the
presence of the C-terminal peptide (not shown), indicating that
the observed effects were not due to a change in calcium chan-
nel function. We were, however, unable to detect consistent
effects of Mint1 RNAi knockdown on synaptic transmission
(n  25). This could in principle suggest that Mint1 might not
play a key role in synaptic transmission (but see below). Alter-
natively, it is possible that the knockdown may have been
inefficient/incomplete or perhaps that compensation from an-
other Mint isoform could have occurred.
To test further the role of Mint1 and CASK in synaptic
transmission, we generated separate peptides corresponding to
the CASK and Mint1 binding regions, and we injected them
individually into VD4 neurons 1 h prior to recording. Whereas
injection of the CASK interacting CT3 peptide did not affect
synaptic transmission in 6 of 7 synaptic pairs examined (Fig.
7C), the Mint1 interacting CT2 peptide dramatically inhibited
synaptic transmission such that 4 of 10 synapses exhibited no
detectable transmission, and in the remaining cells EPSP am-
plitudes were dramatically reduced (Fig. 7C). Injection of a
DDKC mutant CT2 peptide (which is incapable of binding
Mint1, see Fig. 7A) resulted in normal EPSPs in 7 of 8 exper-
iments, suggesting that the effects of the Mint1-interacting
peptide were indeed specific for the Mint1-calcium channel
interaction. Our data are thus consistent with a mechanism in
which Lymnaea synaptic transmission is dependent on a
Mint1-calcium channel interaction, as well as on the presence
of CASK.
To determine whether the expression of the calcium channel
splice variant and synaptic/scaffolding proteins are dynami-
cally regulated during synaptogenesis, we carried out qPCR
analysis of pre- and postsynaptic VD4 and LPeD1 neurons that
were either separately cultured or synaptically paired over-
night prior to mRNA extraction but were otherwise cultured
under identical conditions. As shown in Fig. 7D, the expression
of the LCav2 channel splice variants were not altered during
synapse formation, consistent with our previous finding that
the development of calcium hotspots during synapse formation
appears to involve a redistribution of existing channels (16).
Furthermore, there were no obvious gene expression changes
observed in SNARE proteins or synaptotagmin1 (see also inset
to Fig. 7D). Interestingly, whereas gene expression of Mint1
was almost undetectable in unpaired neurons (see inset), ro-
bust Mint1 expression was detected after pairing, indicating
that Mint1 may serve as key signaling element during synapse
formation. We were unable to perform a similar analysis for
CASK, because CASK expression levels were only barely over
the detection limit (requiring36 PCR cycles), thus preventing
us from reliably determining changes in CASK expression.
Nonetheless, given the profound effects of CASK RNAi knock-
down, together with the observations that both Mint1 and
CASK bind to specific calcium channel splice variant whose
expression is essential for synaptic transmission, suggests that
these proteins could regulate synaptic activity via their inter-
action with calcium channels.
DISCUSSION
Absence of Coupling of SNARE Complexes with Presynaptic
Calcium Channels—The Lymnaea soma-soma synapse is an
emerging model that allows convenient access to identified
single pre- and postsynaptic neurons (13, 16). These synapses
are morphologically and electrophysiologically similar to those
in vivo and require new gene transcription and de novo protein
synthesis to form (13). Moreover, as in mammalian synapses,
target cell-specific calcium hotspots develop at the active zones
during synapse formation, which appear to result from a redis-
tribution of existing calcium channels rather than the synthe-
sis of new channels (16). Detailed analyses of the molecular
players involved in Lymnaea synapse formation/function have
so far been hampered by a lack of information about the Lym-
naea genome. We have thus cloned the entire complement of
voltage-gated calcium channels, plus a number of key synaptic
and scaffolding proteins from Lymnaea to provide a novel per-
spective regarding the relationship between SNARE proteins,
calcium channels, and scaffolding proteins during transmitter
release at the level of individual pre- and postsynaptic neurons.
Although the SNARE complexes are important for transmit-
ter release from Lymnaea neurons, this role appears to be
independent of their coupling with calcium channels. Our re-
sults therefore contrast with those obtained in vertebrates
where a direct association between SNARE complexes and
calcium channels was deemed necessary for transmitter re-
lease (2, 5). Indeed, the synaptic protein interaction site found
in mammalian N-type and P/Q-type calcium channels (4–6) is
conspicuously absent in invertebrate Cav2 orthologs such as in
C. elegans, Drosophila (10), and Lymnaea. It has remained
unclear as to whether synaptic transmission in invertebrates
occurs independently of a calcium channel SNARE protein
interaction, or whether invertebrate calcium channels might
perhaps harbor a synaptic protein interaction site that is struc-
turally unrelated to that found in mammals (9, 28–31). Be-
cause syntaxin1A, SNAP-25, and synaptotagmin1 mainly as-
sociate through exposed, cytoplasmic surfaces, any putative
synaptic binding domain on the calcium channel would most
likely be confined to one of the intracellular loops. Yet, in
pull-down assays and/or in yeast two-hybrid assays, we were
unable to detect a physical interaction of these proteins with
any of the major intracellular regions of the LCav2 channel,
indicating that they do not directly associate with LCav2. The
injection of mammalian synprint peptides (but not LCav2 II–III
linker peptides) nonetheless inhibited synaptic activity without
affecting calcium channel function, suggesting that these pep-
tides are capable of non-specifically interfering with synaptic
transmission downstream of calcium channels. Alternatively,
synprint may act as an interaction domain in other as yet
unidentified proteins more distantly associated with transmit-
ter release. Our observation of a synprint peptide effect in a
synapse where calcium channels are apparently uncoupled
from SNAREs raises the possibility that similar nonselective
effects could have occurred when this peptide was injected into
mammalian SCG neurons to uncouple the SNARE complex
from voltage-gated calcium channels (2, 7). If so, this would
weaken the interpretation that a direct physical coupling be-
tween calcium channels and the SNARE complex must be a
prerequisite for transmitter release at synapses to ensure prox-
imity of calcium channels to the release sites. The synprint
region may perhaps serve to optimize the efficiency of synaptic
transmission or to serve as a site for regulating calcium chan-
nel activity (2, 12, 19, 32–33). Thus, rather than being univer-
sally required, the presence of a synaptic protein interaction
site in calcium channels may be an evolutionary specialization
in the vertebrates.
Possible Role of LCav2a Channels in Presynaptic Transmitter
Release—Despite the absence of a synprint motif, calcium
hotspots appear to form at the active zones during synapse
formation (16). Interestingly, this appears to involve a redis-
tribution of existing calcium channels, rather than the new
synthesis of channel protein (16), consistent with our observa-
tion that transcript levels of individual calcium channel splice
variants did not change during synapse formation. Given that
synaptic transmission in Lymnaea appears to be critically de-
pendent on the LCav2a channel (i.e. the one with the long C
terminus that is capable of interacting with Mint1 and CASK),
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we propose that interactions between the C terminus and these
proteins may be involved in channel clustering at the active
zones and perhaps in synaptic transmission per se. This would
be consistent with the fact that the Mint1 and CASK interac-
tion domains are highly conserved in synaptic calcium chan-
nels, and with recent evidence suggesting that synaptic target-
ing of N-type calcium channels in rat hippocampal neurons is
dependent on the C-terminal region of these channels (27).
Although Mint1 and CASK can both interact with the C-
terminal region of the channel and have both been implicated
in protein targeting functions, they do not appear to have
identical cellular functions, with CASK having a role in devel-
opmental processes and Mint1 having a closer association with
synaptic vesicle exocytosis (34–36). The observations that the
expression of Mint1 appeared to occur only following cell-cell
contact (see Fig. 7D) and that Lymnaea synaptic transmission
was blocked by injection of Mint1 interacting DDWC-CT2 pep-
tides 1 h prior to recording suggest that the Mint calcium
channel interaction may mediate a more acute role in synaptic
transmission. In contrast, the CASK interaction may be of
greater importance in the earlier stages of synapse formation/
channel clustering. This would fit with our observation that
injection of the CASK interacting CT3 peptide 1 h prior to
recording did not affect synaptic transmission. We also note
that the RNAi knockdown of CASK that resulted in the loss of
synaptic transmission was initiated prior to synapse formation,
again perhaps consistent with an early role of CASK. However,
although our data provide evidence for an important role of
CASK and the LCav2 C-terminal region, we must acknowledge
two potential caveats. First, because we did not examine any
putative effects of the CT3 peptide during earlier stages of
synapse formation, our data do not permit us to determine
whether a physical interaction between CASK and the C ter-
minus of the LCav2 channel is indeed of physiological signifi-
cance. Second, although a single point mutation in the CT2
peptide prevented both Mint1 binding and, in parallel, abol-
ished the physiological effects of this peptide, we cannot rule
out the possibility that another protein recognizing the Mint1-
binding site on the LCav2 calcium channel could be antago-
nized by the CT2 peptide. Our experimental data at this stage
do not allow us to firmly implicate Mint1 in synaptic transmis-
sion. Further experiments will therefore be needed to prove a
role of Mint1 in synaptic transmission, and to define the tem-
poral sequence of the involvement of CASK (and possibly
Mint1) in synapse formation and synaptic activity.
Taken together, it appears that an interaction of presynaptic
calcium channels with scaffolding proteins appears to be more
fundamental for synaptic transmission than direct coupling to
syntaxin, SNAP-25 and synaptotagmin. This may have impli-
cations for understanding the roles of other types of presynap-
tic calcium channels that lack the synprint motif, such as
certain splice variants of the human N-type channel (37) and
apparently all types of non-vertebrate calcium channels iden-
tified to date. Such differences likely contribute to the observed
synaptic diversity across cell types and species (38).
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